← Back to overview

EW Edwards Lifesciences Corporatio

Health Care Equipment · $82.63 -1.42%
EN PL
Price Alert:

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
51.0
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
80.74 / 79.77 / 50.35
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
1.63 / 1.12
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
49.2
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
47.58B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
72.30 – 96.29
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Edwards Lifesciences Corporatio is trading at $82.63, -1.42% versus the previous close. The price sits roughly in the middle of its 52-week range.
RSI is in a neutral range — no strong overbought/oversold signal.
The 50-day average is above the 200-day average ("golden cross" territory) — a commonly watched bullish signal.
MACD is above its signal line — momentum currently leans positive.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium
Simply Wall St. · 2026-07-25 05:11
Edwards, The 'Cleanest Large-Cap Medtech Story,' Reverses After Quarterly Beat
Investor's Business Daily · 2026-07-24 20:19
Edwards Lifesciences Seen Building on Catalyst Pipeline, RBC Says
MT Newswires · 2026-07-24 15:58
SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls
The Fly · 2026-07-24 13:32
Edwards lifts FY26 growth outlook following steady Q2 performance
Medical Device Network · 2026-07-24 13:18
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises
Zacks · 2026-07-24 12:54
Deutsche Bank Adjusts Edwards Lifesciences Price Target to $103 From $100, Maintains Buy Rating
MT Newswires · 2026-07-24 12:49
Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary
Moby · 2026-07-24 12:30
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.